Protab

Developing immunotherapeutic mAb for autoimmune inflammatory diseases

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2005 language protab.co.il

2 investors on record.

Investor type	Count	Share
Venture capital	2	100%

Coming soon